JPRN-UMIN000015599已完成未知
Special Drug Use-results Survey for Long-term Administration of Invega 3mg/6mg/9mg Tablet - Special Drug Use-results Survey for Long-term Administration of Invega 3mg/6mg/9mg Tablet
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Special Drug Use-results Survey for Long-term Administration of Tramcet Combination TabletsChronic painJPRN-UMIN000015901Janssen Pharmaceutical K.K.1,200
已完成
不适用
Special Drug Use-results Survey for Long-term Administration of Durotep MT Patch 2.1mg/ 4.2mg/ 8.4mg/ 12.6mg/ 16.8mgChronic painJPRN-UMIN000015898Janssen Pharmaceutical K.K.500
已完成
不适用
Special Drug Use-results survey for long-term administration of Stelarapsoriasis vulgaris, psoriatic arthritisJPRN-UMIN000015899Janssen Pharmaceutical K.K.1,500
已完成
不适用
Special Drug Use-results survey for long term administration of Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral SolutioMild to moderately severe dementia of the Alzheimer's typeJPRN-UMIN000017151Janssen Pharmaceutical K.K.600
已完成
不适用
Special Drug Use-Results Survey for Long-term Use of XEPLION TRI Aqueous Suspension for IM Injection 175 mg, 263 mg, 350 mg, and 525 mg SyringeSchizophreniaJPRN-UMIN000042033Janssen Pharma990